Microbiota-associated post-translational remodeling of immune cell states in gastrointestinal cancer
- 1Department of Hepatobiliary Surgery, Shannan City People’s Hospital
- 2Department of Cardiology, Wenzhou TCM Hospital of Zhejiang Chinese Medical University
- 3Department of Colorectal Surgery, The First Affiliated Hospital, Zhejiang University School of Medicine
Abstract
Microbial communities influence gastrointestinal (GI) cancer through metabolic exchange and immune regulation. Post-translational modifications (PTMs) can connect these signals to changes in chromatin, protein function and immune-cell states. This narrative review examines histone and non-histone modifications to explore how microbial inputs and host metabolism intersect in the regulation of immune-cell states and tumor immunity. Microbial metabolites can influence acyl-donor availability and PTM enzyme activity, while microbial sensing can reprogram host metabolism and downstream modification states. These routes provide a framework for understanding changes in lymphoid and myeloid cell function, whose consequences for tumor immunity depend on cellular and disease context. Among the studies assessed, evidence linking microbial interventions to immune-cell PTM changes in GI cancer is concentrated in colorectal cancer and its metastatic models. Findings from nonmalignant models, other cancers and host metabolic studies provide complementary insights into potentially relevant mechanisms. Their extension to microbiota–immune interactions in GI tumors requires attention to both microbial involvement and the functional contribution of specific modifications. Understanding how microbial inputs converge with host metabolism at the level of PTM regulation may reveal opportunities to modulate tumor immunity. Defining metabolite sources and cellular exposure, resolving the functions of individual modifications, and validating pathways in relevant anatomical and therapeutic settings will be important for identifying mechanisms that can inform biomarker and therapeutic development.
Related
- Mechanisms and Clinical Translational Prospects of the Microbiota–Gut–Lung Axis in Connective Tissue Disease-Associated Interstitial Lung Disease
- Network Pharmacology-Assisted Multi-Omics Analysis of Gut Microbiota-Host Metabolic Remodeling and Hepatic HPD/GSTM3-Associated Redox Responses Following Shanqijing Treatment in STZ-Induced Diabetic Mice.
- Bladder cancer immune microenvironment: immune-cell distribution, disease associations, treatment remodeling, and baseline immune features associated with treatment response and prognosis
- Tracing specificity of immune landscape remodeling associated with distinct anticancer treatments
- Nervonic acid ameliorates high-fat diet-induced obesity and is associated with gut microbiota, fecal metabolic remodeling, and short-chain fatty acid profiles
BibTeX
@article{qiangbadanzeng2026microbiotaassociated,
title = {{Microbiota-associated post-translational remodeling of immune cell states in gastrointestinal cancer}},
author = {Qiangbadanzeng and Luobudunzhu and Yuelin Qin and Hongliang Yu and Danzeng Dedan and Zuchao Jiang and Youheng Jiang},
journal = {Frontiers in Oncology},
year = {2026},
month = nov,
doi = {10.3389/fonc.2026.1981191},
url = {https://www.frontiersin.org/articles/10.3389/fonc.2026.1981191/full},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Microbiota-associated post-translational remodeling of immune cell states in gastrointestinal cancer
AU - Qiangbadanzeng
AU - Luobudunzhu
AU - Yuelin Qin
AU - Hongliang Yu
AU - Danzeng Dedan
AU - Zuchao Jiang
AU - Youheng Jiang
PY - 2026
DA - 2026/11/09
JO - Frontiers in Oncology
DO - 10.3389/fonc.2026.1981191
UR - https://www.frontiersin.org/articles/10.3389/fonc.2026.1981191/full
AB - Microbial communities influence gastrointestinal (GI) cancer through metabolic exchange and immune regulation. Post-translational modifications (PTMs) can connect these signals to changes in chromatin, protein function and immune-cell states. This narrative review examines histone and non-histone modifications to explore how microbial inputs and host metabolism intersect in the regulation of immune-cell states and tumor immunity. Microbial metabolites can influence acyl-donor availability and PTM enzyme activity, while microbial sensing can reprogram host metabolism and downstream modification states. These routes provide a framework for understanding changes in lymphoid and myeloid cell function, whose consequences for tumor immunity depend on cellular and disease context. Among the studies assessed, evidence linking microbial interventions to immune-cell PTM changes in GI cancer is concentrated in colorectal cancer and its metastatic models. Findings from nonmalignant models, other cancers and host metabolic studies provide complementary insights into potentially relevant mechanisms. Their extension to microbiota–immune interactions in GI tumors requires attention to both microbial involvement and the functional contribution of specific modifications. Understanding how microbial inputs converge with host metabolism at the level of PTM regulation may reveal opportunities to modulate tumor immunity. Defining metabolite sources and cellular exposure, resolving the functions of individual modifications, and validating pathways in relevant anatomical and therapeutic settings will be important for identifying mechanisms that can inform biomarker and therapeutic development.
SN - 2234-943X
ER -